(Q42457719)

31 October 2017

title

Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma (English)

1 reference

31 October 2017

1 reference

A H M M Arits

1

1 reference

31 October 2017

E Spoorenberg

2

1 reference

31 October 2017

K Mosterd

3

1 reference

31 October 2017

P Nelemans

4

1 reference

31 October 2017

N W J Kelleners-Smeets

5

1 reference

31 October 2017

B A B Essers

6

1 reference

31 October 2017

language of work or name

English

0 references

publication date

28 October 2014

1 reference

British Journal of Dermatology

31 October 2017

published in

1 reference

31 October 2017

volume

171

1 reference

31 October 2017

issue

6

1 reference

31 October 2017

page(s)

1501-1507

1 reference

Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005.

31 October 2017

cites work

1 reference

A systematic review of worldwide incidence of nonmelanoma skin cancer

21 January 2018

1 reference

Skin cancer is among the most costly of all cancers to treat for the Medicare population

21 January 2018

1 reference

Guidelines for the management of basal cell carcinoma

21 January 2018

1 reference

Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial

21 January 2018

1 reference

Pulling cost-effectiveness analysis up by its bootstraps: a non-parametric approach to confidence interval estimation.

21 January 2018

1 reference

Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma

21 January 2018

1 reference

Cost-effectiveness of treatment of superficial basal cell carcinoma: surgical excision vs. imiquimod 5% cream

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJD.13066

1 reference

31 October 2017

1 reference